Literature DB >> 7459267

Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis.

D Tsambaos, C E Orfanos.   

Abstract

The effects of the aromatic retinoid RO 10-9359 on the fine structure of psoriatic dermis were investigated by electron microscopy in five patients after 1, 2, and 3 weeks of treatment (I mg/kg/day). Our findings show that aromatic retinoid, additionally to its epidermal effects, exerts a distinct influence on dermal components in psoriasis. Ultrastructural evidence is provided suggesting that this drug stimulates lymphocytes and monocytes, promoting their differentiation into Sézary-like lymphocytic cells, activated macrophages and dermal Langerhans cells. The appearance of these immunocompetent cell lines may modulate the cell-mediated immune response in psoriasis, obviously reflecting a pharmacological action of the drug additional to its definite influence on epidermal keratinization.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7459267     DOI: 10.1111/j.1365-2133.1981.tb01709.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Ultrastructural morphometric analysis of normal human lymphocytes stimulated in vitro with mitogens and antigens.

Authors:  C M Payne; M J Hicks; A Kim
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

2.  Effect of orally administered aromatic retinoid on murine Langerhans cells.

Authors:  T Shiohara; M Kobayashi; H Narimatsu; M Nagashima
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 3.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

4.  Epidermal Langerhans cells in erythrokeratodermia variabilis. Histochemical and ultrastructural investigations before and after treatment with etretinate (RO 10-9359).

Authors:  J G van der Schroeff; D J Ruiter; G T Bots
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin.

Authors:  A Ranki; J Lauharanta; L Kanerva
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

6.  Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.

Authors:  L O Kanerva; E Johansson; K M Niemi; J Lauharanta; O P Salo
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

7.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

8.  Synthetic retinoids inhibit histamine release from isolated human mast cells.

Authors:  D Eichelberg; W Schmutzler
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

9.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.